Yadava Mrinal, Bala Rupa
Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Oregon, United States of America.
Turk Kardiyol Dern Ars. 2015 Jun;43(4):392-401. doi: 10.5543/tkda.2015.53333.
Cardiac sarcoidosis is an underdiagnosed condition that may be present in as many as 25% of patients with systemic sarcoidosis. It is associated with significant morbidity and mortality in affected individuals. The presentation of cardiac involvement in sarcoidosis includes sudden death in the absence of preceding symptoms, conduction disturbances, ventricular arrhythmias, and heart failure. A scarcity of randomized data and a lack of prospective trials underlies the contention between experts on the most appropriate strategies for diagnosis and therapy. This review focuses on the electrophysiological sequelae of the disease, with an emphasis on current diagnostic guidelines, multimodality imaging for early detection, and the role of various therapeutic interventions. Multicentre collaboration is necessary to address the numerous unanswered questions pertaining to management of this disease.
心脏结节病是一种诊断不足的疾病,在多达25%的系统性结节病患者中可能存在。它与受影响个体的显著发病率和死亡率相关。结节病心脏受累的表现包括无前驱症状的猝死、传导障碍、室性心律失常和心力衰竭。随机数据的匮乏和前瞻性试验的缺乏导致专家们在最合适的诊断和治疗策略上存在争议。本综述聚焦于该疾病的电生理后遗症,重点关注当前的诊断指南、用于早期检测的多模态成像以及各种治疗干预措施的作用。多中心合作对于解决与该疾病管理相关的众多未解答问题是必要的。